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EDITORIAL ANNOUNCEMENT
An appreciation of Dr Michael Moore
Editor, BJC, 1979-1988
Now that the transition to the new editorial team of the BJC is complete, it is appropriate to pay
tribute to the now ex-editor, Michael Moore. Michael left the Paterson Institute, where he had been
head of the immunology group for 15 years, to take up a post in industry in July 1988. I do not recall it
now, but he says that, when he told me that he wished to resign as editor, I responded by saying that
'no one is indispensable'. I am quite prepared to justify that view by pointing to the fact that we have
had a smooth transition to a new editor and, moreover, we have moved the editorial office from
Manchester to Cambridge inside a year of learning that Michael was deserting us. I concede, however,
that he might justifiably feel that I was being somewhat ungenerous about his contribution to the BJC.
Let me put that right now. He was a superb editor who, over a period of years, transformed the BJC
into one of the world's leading cancer journals. He worked tremendously hard for the Journal, as well
as running his own successful research programme. His attention to detail was impressive - he did much
of the sub-editing himself. He has a great facility with the English language and enjoys manipulating
words to get precise meanings - a valuable talent in an editor. He built up a powerful network of
referees throughout the world and lost no opportunity at meetings and conferences to rope new people
into the work of the Journal. His scientific judgement, both strategically and tactically was good. The
developments of the Journal, including the stronger emphasis on clinical research, were planned years
ahead but he also had the journalist's nose for a good story. However, the quality which made him such
a good editor (and one that will stand him in good stead in industry) was his ability to take correct
decisions quickly and firmly. Unsuccessful authors would find that, though the rejection letter was
always polite, even kindly, it could not be interpreted as anything other than an outright no. If there
was room for manoeuvre that was what he intended.
Michael believed strongly, as I do, in the editorial independence of the Journal. If submitted papers
stand up to rigorous critical peer review they are published even if the views expressed are not in accord
with current dogma or are perhaps politically sensitive.
As Chairman of the Editorial Board for the past 5 years, I have had an easy ride. Michael always
consulted me about important issues and we often took difficult decisions together- but it was he who
put in the hard graft. It may seem curious, when dealing with so serious a topic, but it was fun working
with him. Even when things went wrong, as occasionally they did, we usually ended up by managing to
view the catastrophe as just one more example of life's rich pattern.
I look forward to working with Peter Twentyman, the new editor, and he will, in time, put his own
stamp on the Journal, but I will miss Michael, his almost obsessional devotion to the Journal, his skill
in handling people and his wit. I would like to thank him on behalf of the Cancer Research Campaign
and all of those associated with the refereeing, editing, management and production of the BJC for his
many years of outstanding editorship.
Lastly, and before this sounds too much like an obituary, I would like to wish him well in his new
career. You, the readers, may hear a little less of Michael Moore in the future, but I know he will
always be looking over my shoulder to make sure we uphold and enhance the high standards he set.
D.G. Harnden
Chairman, Editorial Board
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